2021
DOI: 10.1016/j.ijcha.2021.100918
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac cytokine therapy? Relevance of targeting inflammatory mediators to combat cardiac arrhythmogenic remodeling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 20 publications
0
4
0
Order By: Relevance
“…Our current study suggests that novel therapeutic approaches may include inflammation-resolution strategies to prevent or cure the inflammatory status, which is commonly observed in AF and RHD. 2 , 38 , 52–55 In addition, SERCA2a is also dysregulated in both PAH and AF, 56 , 57 suggesting that strategies promoting the normal expression and activity of SERCA2a may contribute to preventing AF occurrence in RHD-induced arrhythmogenicity. In a rabbit model of left heart failure, upregulation of SERCA2a was associated with LA cardio-protection and reduction of atrial vulnerability to arrhythmogenicity.…”
Section: Discussionmentioning
confidence: 99%
“…Our current study suggests that novel therapeutic approaches may include inflammation-resolution strategies to prevent or cure the inflammatory status, which is commonly observed in AF and RHD. 2 , 38 , 52–55 In addition, SERCA2a is also dysregulated in both PAH and AF, 56 , 57 suggesting that strategies promoting the normal expression and activity of SERCA2a may contribute to preventing AF occurrence in RHD-induced arrhythmogenicity. In a rabbit model of left heart failure, upregulation of SERCA2a was associated with LA cardio-protection and reduction of atrial vulnerability to arrhythmogenicity.…”
Section: Discussionmentioning
confidence: 99%
“…The NLRP3 inflammasome is implicated in the development and progression of multiple cardiovascular maladies such as systemic hypertension, myocardial infarction, or cardiac arrhythmias [ 114 ]. The assembled and activated NLRP3 inflammasome promotes the maturation of the inactive isoforms pro-interleukin-(IL)-1β and pro-IL-18 into active IL-1β and IL-18 [ 109 , 113 , 114 , 115 ]. Moreover, NLRP3-induced gasdermin-D (GSDMD) cleavage into N-terminus GSDMD (GSDMD-Nt) generates the formation of pores through the cellular membrane allowing the products of the inflammasome activity, including IL-1β and IL-18 to be excreted and play further autocrine, paracrine, and endocrine pro-inflammatory signaling [ 116 ].…”
Section: Proposed Mechanisms Underlying the Association Between Pesti...mentioning
confidence: 99%
“…Various chronic cardiac inflammatory diseases, including AF, have in common the overexpression of NLRP3 inflammasome-related genes and components [88][89][90][91][92]. The NLRP3 inflammasome senses PAMPs and DAMPs signals to promote proinflammatory response to infection or injury by stimulating secretion of proinflammatory interleukins such as IL1β, IL6, and IL18 [93,94]. Genetic deficiency of NLRP3 was associated with reduced expression of proinflammatory cytokines (TNFα, IL1β, IL6), reduced secretion of proinflammatory PGE 2 and LTB 4 , and increased expression of LXA 4 and LXB 4 , which suggests that presence of NLRP3 may negatively influence the LM-class switching and prevent resolution process during acute inflammation [95].…”
Section: Nlrp3-inflammasome Il1 and Il6 Inhibitionmentioning
confidence: 99%